Medical approach to the hypotensive patient and the patient in shock.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001243:Assisted Circulation / Q000379:methods; D001337:Autonomic Agents / Q000627:therapeutic use; D002496:Central Venous Pressure; D004562:Electrocardiography; D006801:Humans; D007022:Hypotension / Q000628:therapy; D007263:Infusions, Parenteral; D008353:Mannitol / Q000627:therapeutic use*; D010952:Plasma Substitutes / Q000627:therapeutic use; D012769:Shock / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D012770:Shock, Cardiogenic / Q000628:therapy*; D012772:Shock, Septic / Q000628:therapy*; D013256:Steroids / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000900:Anti-Bacterial Agents; D001337:Autonomic Agents; D010952:Plasma Substitutes; D013256:Steroids; D008353:Mannitol